David Gindler specializes in complex commercial litigation, with an emphasis on patent, trade secret, and related intellectual property disputes. His work spans a broad array of industries and technologies, ranging from biotechnology, medical devices, computer architecture, microprocessor design, advanced semiconductor materials, financial services, and business methods.
Mr. Gindler appears in The Best Lawyers in America in Intellectual Property Law; Chambers USA as a "Leading Individual" in Intellectual Property and Patent Law; The International Who's Who of Life Sciences Lawyers; LMG Life Sciences as a "Life Sciences Star"; the IAM Patent 1000-The World's Leading Patent Professionals; Managing Intellectual Property "IP Stars" and Southern California's Top Rated Lawyers. Mr. Gindler has also been selected for inclusion in Southern California "Super Lawyers" by Los Angeles Lawyer Magazine every year the list has been published. The Los Angeles Daily Journal and San Francisco Daily Journal named Mr. Gindler one of California's leading patent litigators in 2008 and one of the "Top Intellectual Property Litigators" in 2014.
Mr. Gindler has represented both established and emerging commercial and non-profit organizations, including CooperVision, PDL BioPharma, Ariosa Diagnostics, Alnylam Pharmaceuticals, INOVA Diagnostics, City of Hope, Aon Corporation, NCR Corporation, Columbia University, Massachusetts Institute of Technology, and Arizona State University.
Mr. Gindler was one of the principal trial attorneys for City of Hope in City of Hope v. Genentech, Inc., in which City of Hope obtained a $302 million compensatory damages award arising from Genentech's failure to pay royalties owed on patents relating to fundamental technology that helped to create the biotechnology industry. The $302 million compensatory damages award was upheld by both the California Court of Appeal and the California Supreme Court, and is the largest jury verdict ever affirmed in a published California appellate decision.
Mr. Gindler is also highly regarded for representing technology, entertainment, and multimedia companies and leading financial institutions in hotly contested matters concerning the protection of trade secrets and related rights. He frequently litigates cases requiring prompt injunctive relief to prevent misappropriation of trade secrets and proprietary information, as well as cases involving allegations of employee raiding and unfair competition.